TrialResults-center.org

Menu

Logiparin LMWH
Description Results NMA

LHN-1 - Logiparin

Group by...

in first

in second

in third

pdf

pathology

Demonstrated benefit and harm

k

venous thrombosis

versus twice daily LMWH

No demonstrated result for efficacy

Trial

control

p<0.05

harm

NS

Siegbahn, 1989

once daily logiparin vs twice daily logiparin

Improvement of thrombus size 2.00 [0.68; 5.85]

Mortality NaN [NaN; NaN]

Haemorraghic events NaN [NaN; NaN]

Recurrent thromboembolic events NaN [NaN; NaN]

Trial

Treatments

Patients

Method

Siegbahn, 1989

Once daily logiparin 150 XaI U/kgp, imag (n=10)

vs.

twice daily logiparin 75 XaI U/kg (n=10)

patients with a venographically confirmed episode of DVT

single blind

Parallel groups

Sample size: 10/10

Primary endpoint:

FU duration:

Modal title

- About - Browse pathology | treatment - Site map - Credits Made with in Lyon - Contact us - Privacy policy -